1. Home
  2. AIMD vs BHAT Comparison

AIMD vs BHAT Comparison

Compare AIMD & BHAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AIMD
  • BHAT
  • Stock Information
  • Founded
  • AIMD 1984
  • BHAT 2010
  • Country
  • AIMD United States
  • BHAT China
  • Employees
  • AIMD N/A
  • BHAT N/A
  • Industry
  • AIMD Biotechnology: Pharmaceutical Preparations
  • BHAT Recreational Games/Products/Toys
  • Sector
  • AIMD Health Care
  • BHAT Consumer Discretionary
  • Exchange
  • AIMD Nasdaq
  • BHAT Nasdaq
  • Market Cap
  • AIMD 16.9M
  • BHAT 12.3M
  • IPO Year
  • AIMD N/A
  • BHAT 2019
  • Fundamental
  • Price
  • AIMD $3.56
  • BHAT $1.77
  • Analyst Decision
  • AIMD
  • BHAT
  • Analyst Count
  • AIMD 0
  • BHAT 0
  • Target Price
  • AIMD N/A
  • BHAT N/A
  • AVG Volume (30 Days)
  • AIMD 96.5K
  • BHAT 1.0M
  • Earning Date
  • AIMD 11-05-2025
  • BHAT 04-30-2025
  • Dividend Yield
  • AIMD N/A
  • BHAT N/A
  • EPS Growth
  • AIMD N/A
  • BHAT N/A
  • EPS
  • AIMD N/A
  • BHAT N/A
  • Revenue
  • AIMD $110,870.00
  • BHAT $18,724,190.00
  • Revenue This Year
  • AIMD N/A
  • BHAT N/A
  • Revenue Next Year
  • AIMD N/A
  • BHAT N/A
  • P/E Ratio
  • AIMD N/A
  • BHAT N/A
  • Revenue Growth
  • AIMD 70.25
  • BHAT N/A
  • 52 Week Low
  • AIMD $2.00
  • BHAT $1.51
  • 52 Week High
  • AIMD $5.00
  • BHAT $45.00
  • Technical
  • Relative Strength Index (RSI)
  • AIMD 52.55
  • BHAT 54.65
  • Support Level
  • AIMD $3.28
  • BHAT $1.62
  • Resistance Level
  • AIMD $3.72
  • BHAT $1.81
  • Average True Range (ATR)
  • AIMD 0.28
  • BHAT 0.17
  • MACD
  • AIMD -0.05
  • BHAT 0.01
  • Stochastic Oscillator
  • AIMD 30.77
  • BHAT 50.98

About AIMD Ainos Inc.

Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.

About BHAT Blue Hat Interactive Entertainment Technology

Blue Hat Interactive Entertainment Technology is focused on commodity trading, including chemicals, jewelry, and precious metals such as gold. It operates a gold and diamond trading and supply chain business. Its business model encompasses physical gold trading, diamond trading, gold derivatives trading, and the development of AI-enabled trading platforms. Its segments include Diamond trading, Commodity trading, Information service, Interactive toys - animation series, and Interactive toys - game series. It derives revenue from Diamond trading. The majority of its revenues are generated in PRC.

Share on Social Networks: